Video education aims to demystify cancer genomic testing
NCT ID NCT05215769
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether watching a short video can improve understanding of tumor genomic testing in 243 adults with metastatic cancer. Participants watch the video and then answer questions to measure their knowledge. The goal is to see if this simple tool helps patients better grasp the purpose and results of genomic testing, which could lead to more informed conversations with their doctors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- educational video
- What this could lead to
- If successful, this video could become a standard tool to help patients better understand their genomic test results and make more informed treatment decisions.
- What could go wrong
- This is an early-stage educational study, not a treatment trial. It may not show a meaningful improvement in patient knowledge or change clinical outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
243 people
The number who actually took part.
- Started
-
Mar 2022
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients must have biopsy-confirmed metastatic cancer * Be \>= 18 years of age * Be undergoing clinical tumor or circulating tumor deoxyribonucleic acid (DNA) NGS Exclusion Criteria: * Exclude patients who are not English- or Spanish-speaking
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anatomic stage IV breast cancer ajcc V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Saint Elizabeth Youngstown Hospital
Youngstown, Ohio, 44504, United States
-
Saint Francis Medical Center
Richmond, Ohio, 23222, United States
-
St. Rita's
Lima, Ohio, 45801, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug cocktail make immunotherapy work better for Hard-to-Treat breast cancer?
- Can we predict and treat cancer wasting better? a new study investigates
- Can a new radiation method tackle multiple tumors at once?
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Digital therapy aims to tame the fear that haunts cancer survivors